Technology Accelerator Fund News
An interdisciplinary team develops an idea that could revolutionize healthcare.
A SUNY researcher has made clinically available a blood test that is useful in the diagnosis and treatment of several pregnancy-related disorders.
SUNY Technology Accelerator Fund investment advances promising therapy.
Device developed at Stony Brook is the first Technology Accelerator Fund (TAF) project to go to market.
Passive solar systems currently employ metal coatings, rather than dyes. ChromaNanoTech plans to incorporate its light-filtering dyes into the plastic itself.
Chris Nomura and his team have engineered E. coli bacteria to produce special polymers that serve as the vehicles for delivering cancer drugs.
University at Albany researcher partners with BioTools to improve crime scene investigations.
The new set of cognitive tests will help doctors and clinicians properly diagnose and manage concussions.
Dr. Mark Stewart re-purposed a vagus nerve stimulator to use the body's nervous system to re-start the heart in a lower-power, more stable alternative to ICDs.
The new therapeutic could be taken in once-weekly doses rather than existing medications that are injected multiple times a day.
Cytocybernetics demonstrates how TAF, START-UP NY and other technology/economic development programs help small businesses grow.
Novel use of nerve conduction data and computer-based analytics provides a better understanding of nerve damage.
SUNY Buffalo State professor invents a new type of video game controller that allows users to manipulate 3-D objects.
New technology that could help patients regrow blood cells after chemotherapy, radiation, or bone marrow transplants may also treat obesity.
Prototype developed by UAlbany’s Rabi Musa saves time and prevents loss of valuable – in some cases, priceless – samples.
TAF investment supports proof-of-concept studies to determine the radiance and fluency of light needed to decrease the growth of pathogens.
Technology could cut in half the time and money needed for pre-clinical trials for new medications.
Glauconix, Inc, which has attracted $575,000 in grants and investments since its founding, is climbing steadily toward its commercial debut.
New companies are advancing innovation in health care and energy efficiency.
Successive TAF awards provide an important boost, enabling the new technology to attract additional support.
SUNY Technology Accelerator Fund invests in treatment that may just take breast cancer cells and turn them off.
The invention can form materials and devices as small as a single atom, and then measure their properties with a high degree of resolution.
Laser based body heater increases weight loss and productivity.
The discovery of an RNA molecule could provide the basis for treating high cholesterol and atherosclerosis.
Optical dyes that are both economical and stable are about to hit the market, thanks to some researchers at Binghamton University.
New fiber optic probe could aid in the management of aortic aneurysms, spinal cord trauma, and spine reconstructive surgery.